New criteria for Alzheimer’s disease: which, when and why?
Open Access
- 20 April 2015
- journal article
- editorial
- Published by Oxford University Press (OUP) in Brain
- Vol. 138 (5), 1134-1137
- https://doi.org/10.1093/brain/awv055
Abstract
This scientific commentary refers to ‘Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage’ by Vos et al. (doi:10.1093/brain/awv029).This publication has 10 references indexed in Scilit:
- Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stageBrain, 2015
- Tau imaging: early progress and future directionsThe Lancet Neurology, 2015
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteriaThe Lancet Neurology, 2014
- Mild cognitive impairment due to Alzheimer disease in the communityAnnals of Neurology, 2013
- Determining cut-points for Alzheimer’s disease biomarkers: statistical issues, methods and challengesBiomarkers in Medicine, 2012
- Clinical amyloid imaging in Alzheimer's diseaseThe Lancet Neurology, 2011
- Mild Cognitive ImpairmentThe New England Journal of Medicine, 2011
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Cerebrospinal fluid and plasma biomarkers in Alzheimer diseaseNature Reviews Neurology, 2010
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteriaThe Lancet Neurology, 2007